Nasdaq-Listed Firm Pivots to DAT Strategy With TON Focus; Scaramucci Joins as Advisor
AlphaTON Capital Corp., formerly Portage Biotech Inc., has announced a financing initiative to acquire approximately $100 million in TON tokens ...
Read moreDetails